Early-Phase Study to Assess Inhibitor Ribociclib in Patients With Recurrent Glioblastoma or Anaplastic Glioma
Clinical trial NCT02345824 · UNKNOWN
Trial details
- NCT number
- NCT02345824
- Sponsor
- University of Virginia
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2019-09-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.